Koers ValiRx Plc London S.E.
Aandelen
GB00B23N9136
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- GBX | - |
|
03/07 | WIJZIGINGEN IN HET MANAGEMENT: Jadestone Energy's CFO Bert-Jaap Dijkstra vertrekt | AN |
19/06 | Voorzitter ValiRx treedt terug | MT |
Omzet 2022 | - | Omzet 2023 | 0,01 0,01 | Marktkapitalisatie | 6,04 mln. 5,54 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -2 mln. -1,83 mln. | Nettowinst (verlies) 2023 | -2 mln. -1,83 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 1,1 mln. 1,01 mln. | Nettoliquiditeiten 2023 | 153K 140K | EV/omzet 2023 | 612.941.875 x |
K/w-verhouding 2022 |
-4,57
x | K/w-verhouding 2023 |
-2,94
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 83,16% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Suzanne Dilly
CEO | Chief Executive Officer | 46 | - |
Gerald Desler
DFI | Director of Finance/CFO | 79 | 01-09-06 |
Chief Tech/Sci/R&D Officer | - | 08-09-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gerald Desler
DFI | Director of Finance/CFO | 79 | 01-09-06 |
Director/Board Member | 57 | 22/04 | |
Suzanne Dilly
CEO | Chief Executive Officer | 46 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,17% | 126 mld. | |
+24,67% | 118 mld. | |
+25,04% | 27,87 mld. | |
-17,74% | 20,95 mld. | |
-15,20% | 16,92 mld. | |
-15,21% | 16,18 mld. | |
+11,91% | 14,84 mld. | |
-47,10% | 14,79 mld. | |
+54,50% | 14,08 mld. |